季報
季度報告
10-Q
2026-05-14
公司在 2026 年 1 月完成包銷公開發行，淨籌集約 3,718 萬美元。
AI 繁中摘要
StreamEx Corp.（股票代號：STEX）呈交了截至 2026 年 3 月 31 日的第一季度 10-Q 報告。公司正全面轉型，由生物醫療技術（PURE EP™ 平台）擴展至數字資產及商品交易技術平台，並於 2025 年 5 月收購了 Streamex Exchange Corporation。
業績方面，本季度收入為零，淨虧損大幅擴大至 4,669 萬美元（去年同期虧損 280 萬美元），主要由於一般及行政開支急增至 3,425 萬美元，當中包括 2,537 萬美元的非現金股票補償費用，以及 1,198 萬美元的債務折價攤銷。營運現金流為負 1,018 萬美元。
重要財務變動：
- 公司在 2026 年 1 月完成包銷公開發行，淨籌集約 3,718 萬美元。
- 於 2 月償還了約 3,850 萬美元的擔保可轉換債券，並將其中部分轉換為普通股，消除了所有可轉換債務。
- 期內出售了約 2,641 萬美元的黃金及約 1,019 萬美元的有價證券，並購入約 1,423 萬美元的黃金金條以支持 GLDY Token 計劃。
- 截至季末，現金餘額為 686 萬美元（年初為 2,032 萬美元），營運資金約 4,260 萬美元。
- 資產負債表上，商譽及無形資產淨額合共約 1.12 億美元，主要來自收購 Streamex Exchange。
管理
展開英文正文
false Q1 --12-31 0001530766 0001530766 2026-01-01 2026-03-31 0001530766 2026-05-13 0001530766 2026-03-31 0001530766 2025-12-31 0001530766 us-gaap:RelatedPartyMember 2026-03-31 0001530766 us-gaap:RelatedPartyMember 2025-12-31 0001530766 STEX:RestrictedGoldMember 2026-03-31 0001530766 STEX:RestrictedGoldMember 2025-12-31 0001530766 us-gaap:GoldMember 2026-03-31 0001530766 us-gaap:GoldMember 2025-12-31 0001530766 STEX:SeriesCNinePercentageConvertiblePreferredStockMember 2026-03-31 0001530766 STEX:SeriesCNinePercentageConvertiblePreferredStockMember 2025-12-31 0001530766 us-gaap:SeriesAPreferredStockMember 2026-03-31 0001530766 us-gaap:SeriesAPreferredStockMember 2025-12-31 0001530766 us-gaap:SeriesBPreferredStockMember 2026-03-31 0001530766 us-gaap:SeriesBPreferredStockMember 2025-12-31 0001530766 us-gaap:SeriesCPreferredStockMember 2026-03-31 0001530766 us-gaap:SeriesCPreferredStockMember 2025-12-31 0001530766 us-gaap:SeriesDPreferredStockMember 2026-03-31 0001530766 us-gaap:SeriesDPreferredStockMember 2025-12-31 0001530766 us-gaap:SeriesEPreferredStockMember 2026-03-31 0001530766 us-gaap:SeriesEPreferredStockMember 2025-12-31 0001530766 us-gaap:SeriesFPreferredStockMember 2026-03-31 0001530766 us-gaap:SeriesFPreferredStockMember 2025-12-31 0001530766 2025-01-01 2025-12-31 0001530766 2025-01-01 2025-03-31 0001530766 us-gaap:CommonStockMember 2025-12-31 0001530766 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001530766 us-gaap:RetainedEarningsMember 2025-12-31 0001530766 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-12-31 0001530766 us-gaap:NoncontrollingInterestMember 2025-12-31 0001530766 us-gaap:CommonStockMember 2024-12-31 0001530766 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001530766 us-gaap:RetainedEarningsMember 2024-12-31 0001530766 us-gaap:NoncontrollingInterestMember 2024-12-31 0001530766 2024-12-31 0001530766 us-gaap:CommonStockMember 2026-01-01 2026-03-31 0001530766 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-03-31 0001530766 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0001530766 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-01-01 2026-03-31 0001530766 us-gaap:NoncontrollingInterestMember 2026-01-01 2026-03-31 0001530766 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001530766 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001530766 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001530766 us-gaap:NoncontrollingInterestMember 2025-01-01 2025-03-31 0001530766 us-gaap:CommonStockMember 2026-03-31 0001530766 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0001530766 us-gaap:RetainedEarningsMember 2026-03-31 0001530766 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-03-31 0001530766 us-gaap:NoncontrollingInterestMember 2026-03-31 0001530766 us-gaap:CommonStockMember 2025-03-31 0001530766 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001530766 us-gaap:RetainedEarningsMember 2025-03-31 0001530766 us-gaap:NoncontrollingInterestMember 2025-03-31 0001530766 2025-03-31 0001530766 STEX:ViralClearMember 2026-03-31 0001530766 STEX:BioSigAIMember 2025-12-31 0001530766 STEX:GLDYServiceCoLLCMember 2026-03-31 0001530766 STEX:GLDYServiceCoLLCMember 2026-01-01 2026-03-31 0001530766 2026-01-01 2026-01-31 0001530766 country:US 2026-03-31 0001530766 country:CA 2026-03-31 0001530766 srt:ConsolidatedEntityExcludingVariableInterestEntitiesVIEMember 2026-03-31 0001530766 us-gaap:SeriesCPreferredStockMember 2026-01-01 2026-03-31 0001530766 us-gaap:SeriesCPreferredStockMember 2025-01-01 2025-03-31 0001530766 us-gaap:EmployeeStockOptionMember 2026-01-01 2026-03-31 0001530766 us-gaap:EmployeeStockOptionMember 2025-01-01 2025-03-31 0001530766 STEX:PerformanceBasedRestrictedStockUnitMember 2026-01-01 2026-03-31 0001530766 STEX:PerformanceBasedRestrictedStockUnitMember 2025-01-01 2025-03-31 0001530766 us-gaap:WarrantMember 2026-01-01 2026-03-31 0001530766 us-gaap:WarrantMember 2025-01-01 2025-03-31 0001530766 us-gaap:RestrictedStockMember 2026-01-01 2026-03-31 0001530766 us-gaap:RestrictedStockMember 2025-01-01 2025-03-31 0001530766 STEX:StreamexExchangeCorporationMember 2025-05-28 2025-05-28 0001530766 STEX:SharePurchaseAgreementMember 2025-05-28 2025-05-28 0001530766 STEX:SharePurchaseAgreementMember 2025-05-28 0001530766 2025-11-04 2025-11-04 0001530766 2025-05-28 2025-05-28 0001530766 us-gaap:CommonStockMember STEX:ThirdpartyConsultantsMember 2026-01-01 2026-03-31 0001530766 us-gaap:CommonStockMember STEX:ThirdpartyConsultantsMember 2026-03-31 0001530766 STEX:ThirdpartyConsultantsMember 2026-01-01 2026-03-31 0001530766 us-gaap:TradeNamesMember 2025-05-28 0001530766 2025-05-28 0001530766 us-gaap:TechnologyBasedIntangibleAssetsMember 2025-05-28 0001530766 STEX:SecuritizationPlatformMember 2025-05-28 0001530766 STEX:BlockchainIntegrationMember 2025-05-28 0001530766 STEX:LegalAndComplianceFrameWorkMember 2025-05-28 0001530766 us-gaap:TradeNamesMember 2026-03-31 0001530766 us-gaap:TradeNamesMember 2025-12-31 0001530766 us-gaap:DevelopedTechnologyRightsMember 2026-03-31 0001530766 us-gaap:DevelopedTechnologyRightsMember 2025-12-31 0001530766 STEX:LegalAndComplianceFrameWorkMember 2026-03-31 0001530766 STEX:LegalAndComplianceFrameWorkMember 2025-12-31 0001530766 us-gaap:PatentsMember 2026-03-31 0001530766 us-gaap:PatentsMember 2025-12-31 0001530766 us-gaap:TradeNamesMember 2026-03-31 0001530766 us-gaap:TradeNamesMember 2025-12-31 0001530766 us-gaap:DevelopedTechnologyRightsMember 2026-03-31 0001530766 us-gaap:DevelopedTechnologyRightsMember 2025-12-31 0001530766 dei:LegalContactMember 2026-03-31 0001530766 dei:LegalContactMember 2025-12-31 0001530766 us-gaap:PatentsMember 2026-03-31 0001530766 us-gaap:PatentsMember 2025-12-31 0001530766 us-gaap:TradeNamesMember 2026-01-01 2026-03-31 0001530766 us-gaap:DevelopedTechnologyRightsMember 2026-01-01 2026-03-31 0001530766 dei:LegalContactMember 2026-01-01 2026-03-31 0001530766 us-gaap:PatentsMember 2026-01-01 2026-03-31 0001530766 us-gaap:TradeNamesMember 2025-01-01 2025-03-31 0001530766 us-gaap:DevelopedTechnologyRightsMember 2025-01-01 2025-03-31 0001530766 dei:LegalContactMember 2025-01-01 2025-03-31 0001530766 us-gaap:PatentsMember 2025-01-01 2025-03-31 0001530766 STEX:ComplianceFrameworkMember 2026-03-31 0001530766 us-gaap:ComputerEquipmentMember 2026-03-31 0001530766 us-gaap:ComputerEquipmentMember 2025-12-31 0001530766 us-gaap:FurnitureAndFixturesMember 2026-03-31 0001530766 us-gaap:FurnitureAndFixturesMember 2025-12-31 0001530766 STEX:TestingAndDemoEquipmentMember 2026-03-31 0001530766 STEX:TestingAndDemoEquipmentMember 2025-12-31 0001530766 us-gaap:LeaseholdImprovementsMember 2026-03-31 0001530766 us-gaap:LeaseholdImprovementsMember 2025-12-31 0001530766 2026-02-26 0001530766 STEX:SharePurchaseAgreementMember 2025-12-09 2025-12-09 0001530766 STEX:SharePurchaseAgreementMember 2025-12-09 0001530766 STEX:SharePurchaseAgreementMember 2025-12-31 0001530766 STEX:SharePurchaseAgreementMember 2025-01-01 2025-12-31 0001530766 STEX:EmpressRoyaltyCorpMember 2026-01-01 2026-01-31 0001530766 STEX:EmpressRoyaltyCorpMember 2026-01-01 2026-03-31 0001530766 STEX:RestrictedMember 2025-12-31 0001530766 STEX:UnrestrictedMember 2025-12-31 0001530766 srt:MaximumMember STEX:BrinksBaileeAgreementMember 2025-11-04 0001530766 STEX:UnrestrictedMember 2026-02-28 0001530766 STEX:RestrictedGoldMember 2026-02-05 0001530766 2026-02-05 2026-02-05 0001530766 STEX:UnrestrictedMember 2026-03-31 0001530766 STEX:TwoRelatedPartyMember 2026-03-31 0001530766 us-gaap:RelatedPartyMember 2026-01-01 2026-03-31 0001530766 STEX:StreamexLtdMember 2026-01-01 2026-03-31 0001530766 STEX:StreamexLtdMember STEX:ChiefInvestOfficerMember 2026-03-31 0001530766 STEX:StreamexLtdMember STEX:GeneralCounselOfficersMember 2026-03-31 0001530766 STEX:StreamexLtdMember 2026-03-31 0001530766 STEX:PremiumFinanceAgreementMember 2025-08-27 0001530766 STEX:PremiumFinanceAgreementMember 2025-08-27 2025-08-27 0001530766 2025-12-17 0001530766 2025-11-04 0001530766 us-gaap:ShareBasedCompensationAwardTrancheOneMember 2025-11-04 0001530766 us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2025-12-17 0001530766 us-gaap:SubsequentEventMember 2027-11-04 0001530766 us-gaap:SubsequentEventMember 2027-12-17 0001530766 us-gaap:SubsequentEventMember 2027-11-04 2027-11-04 0001530766 us-gaap:SubsequentEventMember 2027-12-17 2027-12-17 0001530766 srt:MaximumMember us-gaap:CommonStockMember 2026-01-01 2026-03-31 0001530766 srt:MinimumMember 2026-03-31 0001530766 2026-02-06 0001530766 2026-02-06 2026-02-06 0001530766 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:TradeNamesMember 2025-05-28 0001530766 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember STEX:DevelopedTechnologyMember 2025-05-28 0001530766 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember STEX:LegalAndComplianceFrameWorkMember 2025-05-28 0001530766 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember 2025-05-28 0001530766 us-gaap:FairValueInputsLevel3Member STEX:MeasurementInputCommonStockPriceMember 2026-02-06 0001530766 us-gaap:FairValueInputsLevel3Member STEX:MeasurementInputCommonStockPriceMember 2025-12-31 0001530766 us-gaap:FairValueInputsLevel3Member STEX:MeasurementInputIndicatedConversionPriceMember 2026-02-06 0001530766 us-gaap:FairValueInputsLevel3Member STEX:MeasurementInputIndicatedConversionPriceMember 2025-12-31 0001530766 us-gaap:FairValueInputsLevel3Member STEX:MeasurementInputFloorPriceMember 2026-02-06 0001530766 us-gaap:FairValueInputsLevel3Member STEX:MeasurementInputFloorPriceMember 2025-12-31 0001530766 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputPrepaymentRateMember 2026-02-06 0001530766 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputPrepaymentRateMember 2025-12-31 0001530766 us-gaap:FairValueInputsLevel3Member STEX:MeasurementInputPrepaymentPremiumMember 2026-02-06 0001530766 us-gaap:FairValueInputsLevel3Member STEX:MeasurementInputPrepaymentPremiumMember 2025-12-31 0001530766 us-gaap:FairValueInputsLevel3Member STEX:MeasurementInputRegistrationProbabilityMember 2026-02-06 0001530766 us-gaap:FairValueInputsLevel3Member STEX:MeasurementInputRegistrationProbabilityMember 2025-12-31 0001530766 us-gaap:FairValueInputsLevel3Member 2025-12-31 0001530766 us-gaap:FairValueInputsLevel3Member 2026-01-01 2026-03-31 0001530766 us-gaap:FairValueInputsLevel3Member 2026-03-31 0001530766 us-gaap:FairValueInputsLevel1Member 2026-03-31 0001530766 us-gaap:FairValueInputsLevel1Member 2025-12-31 0001530766 us-gaap:PreferredStockMember 2026-03-31 0001530766 us-gaap:ConvertiblePreferredStockMember 2026-01-01 2026-03-31 0001530766 us-gaap:ConvertiblePreferredStockMember 2026-03-31 0001530766 us-gaap:InvestorMember 2024-01-12 2024-01-12 0001530766 2024-01-12 0001530766 us-gaap:OverAllotmentOptionMember 2026-01-22 2026-01-22 0001530766 2026-01-22 2026-01-22 0001530766 STEX:SalesAgreementMember 2026-01-01 2026-03-31 0001530766 us-gaap:InvestorMember 2026-03-31 0001530766 us-gaap:EmployeeStockOptionMember STEX:TwoThousandTwentyThreeLongTermIncentivePlanMember 2025-09-05 2025-09-05 0001530766 us-gaap:EmployeeStockOptionMember STEX:TwoThousandTwentyThreeLongTermIncentivePlanMember 2025-09-04 0001530766 us-gaap:EmployeeStockOptionMember STEX:TwoThousandTwentyThreeLongTermIncentivePlanMember 2025-09-05 0001530766 us-gaap:EmployeeStockOptionMember STEX:TwoThousandTwentyThreeLongTermIncentivePlanMember 2025-12-30 2025-12-30 0001530766 us-gaap:EmployeeStockOptionMember STEX:TwoThousandTwentyThreeLongTermIncentivePlanMember 2025-12-29 0001530766 us-gaap:EmployeeStockOptionMember STEX:TwoThousandTwentyThreeLongTermIncentivePlanMember 2025-12-30 0001530766 us-gaap:EmployeeStockOptionMember STEX:TwoThousandTwentyThreeLongTermIncentivePlanMember 2026-03-31 2026-03-31 0001530766 us-gaap:EmployeeStockOptionMember 2026-01-01 2026-03-31 0001530766 us-gaap:EmployeeStockOptionMember 2025-01-01 2025-03-31 0001530766 us-gaap:WarrantMember 2026-03-31 0001530766 us-gaap:RestrictedStockUnitsRSUMember 2026-01-01 2026-03-31 0001530766 us-gaap:RestrictedStockUnitsRSUMember 2025-01-01 2025-03-31 0001530766 us-gaap:RestrictedStockUnitsRSUMember 2026-03-31 0001530766 STEX:ThirdPartyConsultantMember 2026-02-01 2026-02-01 0001530766 STEX:CommonStockOneMember 2026-02-01 2026-02-01 0001530766 STEX:CommonStockOneMember 2026-02-01 0001530766 STEX:CommonStockTwoMember 2026-02-01 2026-02-01 0001530766 STEX:CommonStockTwoMember 2026-02-01 0001530766 STEX:CommonStockThreeMember 2026-02-01 2026-02-01 0001530766 STEX:CommonStockThreeMember 2026-02-01 0001530766 STEX:CommonStockFourMember 2026-02-01 2026-02-01 0001530766 STEX:CommonStockFourMember 2026-02-01 0001530766 STEX:CommonStockFiveMember 2026-02-01 2026-02-01 0001530766 STEX:CommonStockFiveMember 2026-02-01 0001530766 us-gaap:ShareBasedCompensationAwardTrancheOneMember 2026-01-01 2026-03-31 0001530766 us-gaap:ShareBasedCompensationAwardTrancheOneMember us-gaap:PerformanceSharesMember 2026-01-01 2026-03-31 0001530766 us-gaap:ShareBasedCompensationAwardTrancheTwoMember us-gaap:PerformanceSharesMember 2026-01-01 2026-03-31 0001530766 us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2026-01-01 2026-03-31 0001530766 us-gaap:ShareBasedCompensationAwardTrancheThreeMember us-gaap:PerformanceSharesMember 2026-01-01 2026-03-31 0001530766 us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2026-01-01 2026-03-31 0001530766 STEX:ShareBasedCompensationAwardTrancheFourMember us-gaap:PerformanceSharesMember 2026-01-01 2026-03-31 0001530766 STEX:ShareBasedCompensationAwardTrancheFourMember 2026-01-01 2026-03-31 0001530766 STEX:ShareBasedCompensationAwardTrancheFiveMember us-gaap:PerformanceSharesMember 2026-01-01 2026-03-31 0001530766 STEX:ShareBasedCompensationAwardTrancheFiveMember 2026-01-01 2026-03-31 0001530766 us-gaap:PerformanceSharesMember 2026-01-01 2026-03-31 0001530766 us-gaap:RestrictedStockMember 2026-01-01 2026-03-31 0001530766 STEX:RestrictedStockOneMember 2026-03-31 0001530766 STEX:RestrictedStockTwoMember 2026-03-31 0001530766 STEX:ThirdPartyConsultantMember 2026-03-16 2026-03-16 0001530766 2026-03-16 2026-03-16 0001530766 us-gaap:CommonStockMember 2026-03-16 2026-03-16 0001530766 2026-03-16 0001530766 us-gaap:PerformanceSharesMember 2026-03-16 2026-03-16 0001530766 STEX:ShareBasedCompensationAwardTrancheMember 2026-03-16 0001530766 us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2026-03-16 0001530766 us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2026-03-16 0001530766 srt:MaximumMember 2026-01-01 2026-03-31 0001530766 STEX:ViralClearPharmaceuticalsIncMember 2026-03-31 0001530766 us-gaap:StockOptionMember 2026-01-01 2026-03-31 0001530766 STEX:ViralClearPharmaceuticalsIncMember 2026-01-01 2026-03-31 0001530766 us-gaap:WarrantMember 2026-01-01 2026-03-31 0001530766 STEX:ViralClearMember 2026-01-01 2026-03-31 0001530766 STEX:OptionsUnder999Member 2026-01-01 2026-03-31 0001530766 STEX:OptionsUnder999Member 2026-03-31 0001530766 STEX:Options1000To1999Member 2026-01-01 2026-03-31 0001530766 STEX:Options1000To1999Member 2026-03-31 0001530766 STEX:Options2000To4999Member 2026-01-01 2026-03-31 0001530766 STEX:Options2000To4999Member 2026-03-31 0001530766 STEX:Options5000To6999Member 2026-01-01 2026-03-31 0001530766 STEX:Options5000To6999Member 2026-03-31 0001530766 us-gaap:MeasurementInputSharePriceMember 2026-03-31 0001530766 us-gaap:MeasurementInputPriceVolatilityMember srt:MinimumMember 2026-03-31 0001530766 us-gaap:MeasurementInputRiskFreeInterestRateMember 2026-03-31 0001530766 us-gaap:MeasurementInputExpectedDividendRateMember 2026-03-31 0001530766 us-gaap:MeasurementInputExpectedTermMember 2026-01-01 2026-03-31 0001530766 STEX:WarrantsAt03000Member 2026-03-31 0001530766 STEX:WarrantsAt03000Member 2026-01-01 2026-03-31 0001530766 STEX:WarrantsAt09547Member 2026-03-31 0001530766 STEX:WarrantsAt09547Member 2026-01-01 2026-03-31 0001530766 STEX:WarrantsAt17800Member 2026-03-31 0001530766 STEX:WarrantsAt33640Member 2026-03-31 0001530766 STEX:WarrantsAt33640Member 2026-01-01 2026-03-31 0001530766 STEX:WarrantsAt40660Member 2026-03-31 0001530766 STEX:WarrantsAt40660Member 2026-01-01 2026-03-31 0001530766 STEX:WarrantsAt44550Member 2026-03-31 0001530766 STEX:WarrantsAt44550Member 2026-01-01 2026-03-31 0001530766 STEX:WarrantsAt44660Member 2026-03-31 0001530766 STEX:WarrantsAt44660Member 2026-01-01 2026-03-31 0001530766 STEX:WarrantsAt46626Member 2026-03-31 0001530766 STEX:WarrantsAt46626Member 2026-01-01 2026-03-31 0001530766 STEX:WarrantsAt49252Member 2026-03-31 0001530766 STEX:WarrantsAt49252Member 2026-01-01 2026-03-31 0001530766 STEX:WarrantsAt49290Member 2026-03-31 0001530766 STEX:WarrantsAt49290Member 2026-01-01 2026-03-31 0001530766 STEX:WarrantsAt51358Member 2026-03-31 0001530766 STEX:WarrantsAt51358Member 2026-01-01 2026-03-31 0001530766 STEX:WarrantsAt71810Member 2026-03-31 0001530766 STEX:WarrantsAt71810Member 2026-01-01 2026-03-31 0001530766 STEX:WarrantsAt75020Member 2026-03-31 0001530766 STEX:WarrantsAt75020Member 2026-01-01 2026-03-31 0001530766 STEX:WarrantsAt79630Member 2026-03-31 0001530766 STEX:WarrantsAt79630Member 2026-01-01 2026-03-31 0001530766 STEX:WarrantsAt90000Member 2026-03-31 0001530766 STEX:WarrantsAt90000Member 2026-01-01 2026-03-31 0001530766 STEX:WarrantsAt95960Member 2026-03-31 0001530766 STEX:WarrantsAt95960Member 2026-01-01 2026-03-31 0001530766 STEX:WarrantsAt100992Member 2026-03-31 0001530766 STEX:WarrantsAt100992Member 2026-01-01 2026-03-31 0001530766 STEX:WarrantsAt102600Member 2026-03-31 0001530766 STEX:WarrantsAt102600Member 2026-01-01 2026-03-31 0001530766 STEX:WarrantsAt104678Member 2026-03-31 0001530766 STEX:WarrantsAt104678Member 2026-01-01 2026-03-31 0001530766 STEX:WarrantsAt113000Member 2026-03-31 0001530766 STEX:WarrantsAt113000Member 2026-01-01 2026-03-31 0001530766 STEX:WarrantsAt132800Member 2026-03-31 0001530766 STEX:WarrantsAt132800Member 2026-01-01 2026-03-31 0001530766 STEX:WarrantsAt480000Member 2026-03-31 0001530766 STEX:WarrantsAt480000Member 2026-01-01 2026-03-31 0001530766 STEX:WarrantsAt616000Member 2026-03-31 0001530766 STEX:WarrantsAt616000Member 2026-01-01 2026-03-31 0001530766 STEX:BioSigAIMember 2025-12-31 0001530766 STEX:BioSigAIMember 2025-01-01 2025-12-31 0001530766 STEX:BioSigAIMember 2024-12-31 0001530766 STEX:BioSigAIMember 2026-01-01 2026-03-31 0001530766 STEX:BioSigAIMember 2026-03-31 0001530766 us-gaap:RestrictedStockUnitsRSUMember STEX:ViralClearPharmaceuticalsIncMember 2025-12-31 0001530766 us-gaap:RestrictedStockUnitsRSUMember STEX:ViralClearPharmaceuticalsIncMember 2026-01-01 2026-03-31 0001530766 us-gaap:RestrictedStockUnitsRSUMember STEX:ViralClearPharmaceuticalsIncMember 2026-03-31 0001530766 STEX:OneOneTwoThousandTwentySixMember STEX:ThirdPartyConsultantMember 2026-01-01 2026-03-31 0001530766 STEX:OneOneTwoThousandTwentySixMember STEX:ThirdPartyConsultantMember us-gaap:RestrictedStockUnitsRSUMember 2026-01-01 2026-03-31 0001530766 STEX:OneEightTwoThousandTwentySixMember STEX:InterimExecutiveChairmanMember 2026-01-01 2026-03-31 0001530766 STEX:OneEightTwoThousandTwentySixMember STEX:InterimExecutiveChairmanMember us-gaap:RestrictedStockUnitsRSUMember 2026-01-01 2026-03-31 0001530766 STEX:OneEightTwoThousandTwentySixMember STEX:ChiefExecutiveOfficierMember 2026-01-01 2026-03-31 0001530766 STEX:OneEightTwoThousandTwentySixMember STEX:ChiefExecutiveOfficierMember us-gaap:RestrictedStockUnitsRSUMember 2026-01-01 2026-03-31 0001530766 STEX:OneTwentySevenTwoThousandTwentySixMember STEX:ThirdPartyConsultantMember 2026-01-01 2026-03-31 0001530766 STEX:OneTwentySevenTwoThousandTwentySixMember STEX:ThirdPartyConsultantMember us-gaap:RestrictedStockUnitsRSUMember 2026-01-01 2026-03-31 0001530766 STEX:TwoOneTwoThousandTwentySixMember STEX:ThirdPartyConsultantMember 2026-01-01 2026-03-31 0001530766 STEX:TwoOneTwoThousandTwentySixMember STEX:ThirdPartyConsultantMember us-gaap:RestrictedStockUnitsRSUMember 2026-01-01 2026-03-31 0001530766 STEX:ThreeThreeTwoThousandTwentySixMember STEX:ThirdPartyConsultantMember 2026-01-01 2026-03-31 0001530766 STEX:ThreeThreeTwoThousandTwentySixMember STEX:ThirdPartyConsultantMember us-gaap:RestrictedStockUnitsRSUMember 2026-01-01 2026-03-31 0001530766 STEX:ThreeSixteenTwoThousandTwentySixMember STEX:ThirdPartyConsultantMember 2026-01-01 2026-03-31 0001530766 STEX:ThreeSixteenTwoThousandTwentySixMember STEX:ThirdPartyConsultantMember us-gaap:RestrictedStockUnitsRSUMember 2026-01-01 2026-03-31 0001530766 STEX:ThreeSixteenTwoThousandTwentySixMember srt:ChiefFinancialOfficerMember 2026-01-01 2026-03-31 0001530766 STEX:ThreeSixteenTwoThousandTwentySixMember srt:ChiefFinancialOfficerMember us-gaap:RestrictedStockUnitsRSUMember 2026-01-01 2026-03-31 0001530766 srt:MaximumMember 2026-03-31 0001530766 srt:MinimumMember 2026-01-01 2026-03-31 0001530766 us-gaap:StockCompensationPlanMember 2026-01-01 2026-03-31 0001530766 us-gaap:PerformanceSharesMember 2025-12-31 0001530766 STEX:PerformanceSharesAndAUMMember 2025-12-31 0001530766 STEX:PerformanceSharesAndAUMMember 2026-01-01 2026-03-31 0001530766 us-gaap:PerformanceSharesMember 2026-03-31 0001530766 STEX:PerformanceSharesAndAUMMember 2026-03-31 0001530766 STEX:RangeOneMember STEX:ViralClearPharmaceuticalsIncMember 2026-01-01 2026-03-31 0001530766 STEX:BioSigAISciencesIncMember 2026-03-31 0001530766 STEX:ViralClearPharmaceuticalsIncMember 2026-03-31 0001530766 STEX:ViralClearPharmaceuticalsIncMember 2025-12-31 0001530766 STEX:BioSigAIMember 2026-03-31 0001530766 STEX:ViralClearPharmaceuticalsIncMember 2026-01-01 2026-03-31 0001530766 STEX:BioSigAISciencesIncMember 2026-01-01 2026-03-31 0001530766 STEX:ViralClearPharmaceuticalsIncMember 2025-01-01 2025-03-31 0001530766 STEX:BioSigAISciencesIncMember 2025-01-01 2025-03-31 0001530766 STEX:StreamexLtdMember 2025-01-01 2025-03-31 0001530766 STEX:ViralClearPharmaceuticalsIncMember 2025-12-31 0001530766 STEX:BioSigAISciencesIncMember 2025-12-31 0001530766 STEX:StreamexLtdMember 2025-12-31 0001530766 STEX:ViralClearPharmaceuticalsIncMember 2026-03-31 0001530766 STEX:BioSigAISciencesIncMember 2026-03-31 0001530766 STEX:ViralClearPharmaceuticalsIncMember 2024-12-31 0001530766 STEX:BioSigAISciencesIncMember 2024-12-31 0001530766 STEX:StreamexLtdMember 2024-12-31 0001530766 STEX:ViralClearPharmaceuticalsIncMember 2025-03-31 0001530766 STEX:BioSigAISciencesIncMember 2025-03-31 0001530766 STEX:StreamexLtdMember 2025-03-31 0001530766 us-gaap:CorporateMember 2026-01-01 2026-03-31 0001530766 us-gaap:CorporateMember 2025-01-01 2025-03-31 0001530766 us-gaap:SubsequentEventMember srt:BoardOfDirectorsChairmanMember 2026-04-17 2026-04-17 0001530766 us-gaap:SubsequentEventMember STEX:ChiefInvestmentOfficerMember us-gaap:RestrictedStockUnitsRSUMember 2026-04-06 0001530766 us-gaap:SubsequentEventMember STEX:ChiefInvestmentOfficerMember us-gaap:RestrictedStockUnitsRSUMember 2026-04-06 2026-04-06 0001530766 us-gaap:SubsequentEventMember STEX:EmploymentAgreementMember STEX:ChiefInvestmentOfficerMember STEX:PerformanceVestingRestrictedStockUnitsMember 2026-05-01 0001530766 us-gaap:SubsequentEventMember STEX:EmploymentAgreementMember STEX:ChiefInvestmentOfficerMember 2026-05-01 2026-05-01 0001530766 us-gaap:SubsequentEventMember STEX:EmploymentAgreementMember STEX:ChiefInvestmentOfficerMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2026-05-01 2026-05-01 0001530766 us-gaap:SubsequentEventMember STEX:EmploymentAgreementMember STEX:ChiefInvestmentOfficerMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2026-05-01 2026-05-01 0001530766 us-gaap:SubsequentEventMember STEX:EmploymentAgreementMember STEX:ChiefInvestmentOfficerMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2026-05-01 2026-05-01 0001530766 us-gaap:SubsequentEventMember STEX:EmploymentAgreementMember STEX:ChiefInvestmentOfficerMember STEX:ShareBasedCompensationAwardTrancheFourMember 2026-05-01 2026-05-01 0001530766 us-gaap:SubsequentEventMember STEX:EmploymentAgreementMember STEX:ChiefInvestmentOfficerMember STEX:ShareBasedCompensationAwardTrancheFiveMember 2026-05-01 2026-05-01 0001530766 us-gaap:SubsequentEventMember STEX:EmploymentAgreementMember us-gaap:CommonStockMember 2026-04-01 2026-05-14 0001530766 us-gaap:SubsequentEventMember us-gaap:CommonStockMember us-gaap:RelatedPartyMember STEX:EmploymentAgreementMember 2026-04-01 2026-05-14 0001530766 us-gaap:SubsequentEventMember STEX:ThirdPartyMember us-gaap:RestrictedStockUnitsRSUMember 2026-04-10 2026-04-10 0001530766 us-gaap:SubsequentEventMember STEX:ThirdPartyMember us-gaap:RestrictedStockUnitsRSUMember STEX:SixMonthAnniversariesMember 2026-04-10 2026-04-10 0001530766 us-gaap:SubsequentEventMember STEX:ThirdPartyMember us-gaap:RestrictedStockUnitsRSUMember STEX:TwelveMonthAnniversariesMember 2026-04-10 2026-04-10 0001530766 us-gaap:SubsequentEventMember STEX:ThirdPartyMember us-gaap:RestrictedStockUnitsRSUMember 2026-04-06 2026-04-06 0001530766 us-gaap:SubsequentEventMember STEX:ThirdPartyMember us-gaap:RestrictedStockUnitsRSUMember us-gaap:PreferredStockMember 2026-05-01 2026-05-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure STEX:Integer iso4217:CAD UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2026 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38659 STREAMEX CORP. (Exact name of registrant as specified in its charter) Delaware 26-4333375 (State or other jurisdiction of incorporation or organization) (IRS Employer Identification No.) 2431 Aloma Avenue, Suite 243 Winter Park, Florida 32792 (Address of principal executive office) (Zip Code) (203) 409-5444 (Registrant’s telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.001 per share STEX The NASDAQ Capital Market Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☒ Smaller reporting company ☒ Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒ As of May 13, 2026, there were 104,274,817 shares of the registrants common stock, par value $0.001 per share, outstanding. Exchangeable and Special Voting Shares: As of May 13, 2026, there were outstanding 77,530,617 exchangeable shares of BST Sub ULC, a wholly owned subsidiary of the registrant. The exchangeable shares are exchangeable for an equal number of the registrants common stock, and carry rights substantially equivalent to the Company’s common stock, including rights to dividends, liquidation preferences, and voting (via a Special Voting Preferred Stock held by a trustee). TABLE OF CONTENTS PART I. FINANCIAL INFORMATION ITEM 1. Financial Statements 3 Condensed Consolidated Balance Sheets (Unaudited) 3 Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) 4 Condensed Consolidated Statements of Changes in Stockholders’ Equity (Unaudited) 5 Condensed Consolidated Statements of Cash Flows (Unaudited) 6 Notes to Condensed Consolidated Financial Statements (Unaudited) 7-38 ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 39-42 ITEM 3. Quantitative and Qualitative Disclosures about Market Risk 43 ITEM 4. Controls and Procedures 43 PART II. OTHER INFORMATION ITEM 1. Legal Proceedings 44 ITEM 1A. Risk Factors 44 ITEM 2. Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities 44 ITEM 3. Defaults Upon Senior Securities 44 ITEM 4. Mine Safety Disclosures 44 ITEM 5. Other Information 44 ITEM 6. Exhibits 45 SIGNATURES 46 2 PART I – FINANCIAL INFORMATION ITEM 1. FINANCIAL STATEMENTS STREAMEX CORP. CONDENSED CONSOLIDATED BALANCE SHEETS (In Thousands, Except Par Value and Share Amounts) March 31, December 31, 2026 2025 (Unaudited) ASSETS Current assets: Cash $6,859 $20,316 Sales tax receivable 59 51 Due from related party - 11 Marketable securities 23,766 9,706 Other assets held for sale – restricted gold - 23,472 Other assets held for sale – gold - 1,000 Prepaid expenses and other assets 15,220 17,339 Total current assets 45,904 71,895 Non-current assets: Other assets held at cost – gold 15,225 - Property and equipment, net 12 25 Intangible assets, net 42,418 44,639 Goodwill 69,758 70,984 Total non-current assets 127,413 115,648 Total assets $173,317 $187,543 LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS’ EQUITY Current liabilities: Accounts payable and accrued expenses, including $907 and $66 to related parties as of March 31, 2026, and December 31, 2025, respectively. $3,179 $2,952 Dividends payable 123 121 Convertible debentures, net - 38,021 Embedded derivative liability - 1,700 Total current liabilities 3,302 42,794 Deferred tax liability 10,669 11,421 Total liabilities 13,971 54,215 Commitments and contingencies (Note 16) - - Mezzanine equity Redeemable Series C 9% Convertible Preferred Stock, $0.001 par value, $1,000 stated value, authorized 4,200 shares, 105 shares issued and outstanding; (liquidation preference of $105; cumulative dividends payable of $123 and $121 as of March 31, 2026, and December 31, 2025, respectively). 105 105 Stockholders’ equity: Preferred stock, $0.001 par value, authorized 1,000,000 shares, designated 200 shares of Series A, 600 shares of Series B, 4,200 shares of Series C, 1,400 shares of Series D, 1,000 shares of Series E, 200,000 shares of Series F Preferred Stock and 1 Special Voting Preferred Stock. - - Common stock, $0.001 par value, authorized 500,000,000 shares, 97,721,696 and 49,805,275 issued and outstanding as of March 31, 2026, and December 31, 2025, respectively. 98 50 Additional paid-in-capital 924,802 850,447 Accumulated other comprehensive (loss) income (1,102) 814 Accumulated deficit (764,813) (718,120) Total stockholders’ equity attributable to Streamex Corp. 158,985 133,191 Non-controlling interest 256 32 Total stockholders’ equity 159,241 133,223 Total liabilities, mezzanine equity and stockholders’ equity $173,317 $187,543 The accompanying notes are an integral part of these unaudited Condensed Consolidated Financial Statements 3 STREAMEX CORP. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) (In Thousands, Except Par Value and Share Amounts) 2026 2025 For the Three Months Ended March 31, 2026 2025 Revenue $- $- Operating expenses: Research and development - 6 General and administrative 34,254 2,957 Depreciation and amortization 1,492 21 Total operating expenses 35,746 2,984 Loss from operations (35,746) (2,984) Other income (expense): Interest expense, net (12,195) - Realized gain on sale of gold 2,938 - Realized gain on marketable securities 484 - Change in fair value of marketable securities (134) - Change in fair value of embedded derivative 497 - Realized loss on extinguishment of convertible debentures (3,057) - Realized loss on investment (119) - Gain on settlement and forgiveness of debt - 199 Other income (expense), net 73 (15) Total other income (expense), net (11,513) 184 Loss before income taxes (47,259) (2,800) Income taxes (benefit) (565) - Net loss (46,694) (2,800) Non-controlling interest 1 (12) Net loss attributable to Streamex Corp. (46,693) (2,812) Preferred stock dividend (2) (2) Preferred stock deemed dividend - - Net loss attributed to Streamex Corp. Common Shareholders (46,695) (2,814) Net loss per common share, basic and diluted $(0.27) $(0.14) Weighted average number of common shares outstanding, basic and diluted 174,590,397 20,787,808 Comprehensive (Loss) Income: Net loss $(46,694) $(2,800) Other comprehensive loss Change in foreign currency translation adjustments (1,916) - Total comprehensive loss (48,610) (2,800) Comprehensive (loss) income attributable to non-controlling interest 1 (12) Comprehensive loss attributable to Streamex Corp. $(48,609) $(2,812) The accompanying notes are an integral part of these unaudited Condensed Consolidated Financial Statements 4 STREAMEX CORP. CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS’ EQUITY (Unaudited) (In Thousands, Except Par Value and Share Amounts) Common stock Shares Amount Additional Paid-in- Capital Accumulated Deficit Accumulated Other Comprehensive Income (Loss) Non- controlling Interest Total Balance, December 31, 2025 49,805,275 $50 $850,447 $(718,120) $814 $32 $133,223 Stock based compensation 6,123,941 6 21,455 - - - 21,461 Exercise of warrants 54,647 - * - - - - - Net proceeds from issuance of common stock in underwritten public offering 13,416,667 13 37,171 - - - 37,184 Conversion of exchangeable shares into common stock 24,571,166 25 (25) - - - - Conversion of convertible debentures into common stock 3,750,000 4 15,756 - - - 15,760 Issuance of equity to noncontrolling interest holders - - - - - 225 225 Preferred stock dividend - - (2) - - - (2) Other comprehensive loss - - - - (1,916) - (1,916) Net loss - - - (46,693) - (1) (46,694) Balance, March 31, 2026 97,721,696 $98 $924,802 $(764,813) $(1,102) $256 $159,241 Common stock Shares Amount Additional Paid-in- Capital Accumulated Deficit Non- controlling Interest Total Balance, December 31, 2024 17,239,096 $17 $253,784 $(255,345) $17 $(1,527) Balance 17,239,096 $17 $253,784 $(255,345) $17 $(1,527) Stock based compensation 1,663,543 2 2,072 - - 2,074 Exercise of warrants 48,996 - * - - - - Sale of common stock under at-the- market offering, net of transaction costs 4,403,166 4 3,878 - - 3,882 Sale of common stock and warrants 758,514 1 817 - - 818 Common stock issued to settle accounts payable 135,000 -* 189 189 Preferred stock dividend - - (2) - - (2) Net (loss) income - - - (2,812) 12 (2,800) Balance, March 31, 2025 24,248,315 $24 $260,738 $(258,157) $29 $2,634 Balance 24,248,315 $24 $260,738 $(258,157) $29 $2,634 *- less than $1 The accompanying notes are an integral part of these unaudited Condensed Consolidated Financial Statements 5 STREAMEX CORP. CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (In Thousands, Except Par Value and Share Amounts) 2026 2025 For the Three Months Ended March 31, 2026 2025 CASH FLOWS FROM OPERATING ACTIVITIES: Net loss $(46,694) $(2,800) Adjustments to reconcile net loss to cash used in operating activities: Depreciation and amortization 1,492 21 Amortization of debt discount and issuance costs 11,979 - Gain on settlement and extinguishment of accounts payable - 199 Non-cash lease expense - 41 Realized gain on sale of gold (2,938) - Realized gain on marketable securities (484) - Change in fair value of marketable securities 134 - Change in fair value of embedded derivative (497) - Realized loss on extinguishment of convertible debentures 3,057 - Realized loss on investment 119 - Stock-based compensation expense 25,370 2,074 Deferred income taxes (565) - Changes in operating assets and liabilities: Accounts receivable 11 - Lease receivables - 17 Sales tax receivable (9) - Prepaid expenses and other assets (1,934) (70) Accounts payable and accrued expenses 780 (555) Operating lease liabilities - (42) Net cash used in operating activities (10,179) (1,115) CASH FLOWS FROM INVESTING ACTIVITIES: Purchases of marketable securities (23,900) - Proceeds from the sale of marketable securities 10,190 - Proceeds from the sale of non-marketable equity investments 25 - Proceeds from sale of gold 26,410 - Purchase of gold assets (14,225) - Net cash used in investing activity (1,500) - CASH FLOWS FROM FINANCING ACTIVITIES: Proceeds from sale of common stock under at-the-market offerings, net of issuance costs - 3,882 Proceeds from sale of common stock and warrants, net of issuance costs - 818 Repayment of finance obligation (546) - Net proceeds from issuance of common stock in underwritten public offering 37,184 - Proceeds from issuance of equity in subsidiary to non-controlling interest holders 225 - Repayment of convertible debentures (38,500) - Net cash (used in) provided by financing activities (1,637) 4,700 Effect of exchange rate change on cash (141) - Net (decrease) increase in cash (13,457) 3,585 Cash, beginning of the period 20,316 142 Cash, end of the period $6,859 $3,727 Supplemental disclosures of cash flow information: Cash paid during the period for interest $403 $- Cash paid during the period for income taxes $- $- Noncash investing and financing activities: Common stock issued in settlement of accounts payable $- $189 Dividend payable on preferred stock charged to additional paid-in-capital $2 $2 Conversion of convertible debentures into common stock $15,760 $- The accompanying notes are an integral part of these unaudited Condensed Consolidated Financial Statements 6 STREAMEX CORP. NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS MARCH 31, 2026 (Unaudited) (in thousands, except par value and share amounts) NOTE 1 – NATURE OF OPERATIONS Business and organization Streamex Corp. (the “Company”, “we”, “us” and “our”) is a technology company with two principal lines of business: (i) digital infrastructure focused on the tokenization and exchange of real-world assets and other commodity-linked financial products and (ii) biomedical technology focused on advanced signal acquisition and processing solutions in electrophysiology through our PURE EP™ platform. On May 28, 2025, the Company acquired Streamex Exchange Corporation (“Streamex Exchange”), a software development company based in Vancouver, British Columbia. In connection with this strategic expansion, on September 12, 2025, the Company changed its corporate name from BioSig Technologies, I